U.S. Sen. Daniel Patrick Moynihan, D-N.Y., and Alan I. Leshner, Ph.D., director of the National Institute on Drug Abuse, will be featured speakers Sept. 18-20 at a special historical conference marking the centennial of the commercial introduction of...
A drug that lowers brain levels of the chemical glutamate – one of the neurotransmitters responsible for relaying messages between neurons – can reverse symptoms of a rat model of schizophrenia without apparent side effects, according to a Yale...
The human immune system, an elegant and intricate biological defense system unmatched in most life forms, may have evolved from a mobile piece of DNA that inserted itself into the mammalian genome more than 450 million years ago. A team of researchers...
David A. Kessler, M.D., J.D., dean of Yale University’s School of Medicine and former commissioner of the Food and Drug Administration (F.D.A.), has accepted an invitation from The Mayday Fund to serve as honorary chairman of its newly formed National...
Beta-blockers are not prescribed for many older patients who could benefit from their use after heart attacks, according to an article in the Aug. 19 issue of The Journal of the American Medical Association (JAMA). In fact, the study found that only...
Although resuscitation is often used with patients suffering from severe congestive heart failure, nearly one in four of those patients who were hospitalized said they did not wish to be resuscitated if their hearts stopped beating, according to a study...
U.S. Sen. Christopher Dodd, D-Conn., will visit the genetic counseling and testing center at the Yale School of Medicine to highlight the need for legislation to safeguard the privacy of genetic information. Such legislation would protect...
Using “knockout” mice – a strain of mice in which a single gene is disabled in order to observe its role during development – researchers at the Yale School of Medicine and Vertex Pharmaceuticals have discovered that an enzyme called Caspase-9 plays...